Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 PLX-PAD for muscle injury after hip arthroplasty for femoral neck fracture
MOH_2018-05-31_002412Phase 3Active, not recruiting
- Sponsor
- Pluri Inc.
- Start
- Apr 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in muscle strain and Neck Of Femur Fracture comparing PLX-PAD with Placebo (2 arms). Primary endpoint: Primary endpoint not reported. Started Apr 2018; status: active, not recruiting.
02
Drugs
PLX-PAD
03
Conditions
muscle strainNeck Of Femur Fracture
Beyond the preview
Go deeper on MOH_2018-05-31_002412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-05-31_002412.